全文获取类型
收费全文 | 3697篇 |
免费 | 486篇 |
国内免费 | 86篇 |
专业分类
耳鼻咽喉 | 41篇 |
儿科学 | 121篇 |
妇产科学 | 45篇 |
基础医学 | 454篇 |
口腔科学 | 92篇 |
临床医学 | 506篇 |
内科学 | 896篇 |
皮肤病学 | 62篇 |
神经病学 | 213篇 |
特种医学 | 395篇 |
外科学 | 486篇 |
综合类 | 298篇 |
一般理论 | 2篇 |
预防医学 | 236篇 |
眼科学 | 46篇 |
药学 | 214篇 |
中国医学 | 2篇 |
肿瘤学 | 160篇 |
出版年
2021年 | 59篇 |
2020年 | 24篇 |
2019年 | 46篇 |
2018年 | 52篇 |
2017年 | 42篇 |
2016年 | 41篇 |
2015年 | 48篇 |
2014年 | 57篇 |
2013年 | 100篇 |
2012年 | 135篇 |
2011年 | 132篇 |
2010年 | 108篇 |
2009年 | 102篇 |
2008年 | 119篇 |
2007年 | 169篇 |
2006年 | 115篇 |
2005年 | 130篇 |
2004年 | 119篇 |
2003年 | 99篇 |
2002年 | 132篇 |
2001年 | 128篇 |
2000年 | 135篇 |
1999年 | 124篇 |
1998年 | 125篇 |
1997年 | 114篇 |
1996年 | 146篇 |
1995年 | 103篇 |
1994年 | 112篇 |
1993年 | 92篇 |
1992年 | 88篇 |
1991年 | 97篇 |
1990年 | 82篇 |
1989年 | 84篇 |
1988年 | 98篇 |
1987年 | 89篇 |
1986年 | 100篇 |
1985年 | 91篇 |
1984年 | 56篇 |
1983年 | 63篇 |
1982年 | 44篇 |
1981年 | 46篇 |
1980年 | 50篇 |
1979年 | 35篇 |
1978年 | 32篇 |
1977年 | 27篇 |
1976年 | 28篇 |
1975年 | 23篇 |
1973年 | 22篇 |
1972年 | 22篇 |
1969年 | 22篇 |
排序方式: 共有4269条查询结果,搜索用时 15 毫秒
11.
B K Weir 《The Australian and New Zealand journal of surgery》1988,58(12):929-936
The development of neurosurgery in Canada is traced through an analysis of the contributions of key early figures in this specialty. The evolution of Canadian training standards is discussed against the background of socio-economic change in the nation at large. 相似文献
12.
13.
Jonas T. Johnson MD Editor John K. Niparko MD Editor-in-Chief Paul A. Levine MD Editor David W. Kennedy MD Editor Pete Weber MD Editor-in-Chief Randal S. Weber MD Editor Michael S. Benninger MD Past Editor in Chief Richard M. Rosenfeld MD MPH Editor in Chief Robert J. Ruben MD Editor in Chief Richard J.H. Smith MD Editor in Chief Robert Thayer Sataloff MD DMA Editor in Chief Neil Weir MA FRCS Editor Emeritus 《Otolaryngology--head and neck surgery》2006,135(6):829-830
14.
15.
Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial 总被引:4,自引:0,他引:4
K C Petruk M West G Mohr B K Weir B G Benoit F Gentili L B Disney M I Khan M Grace R O Holness 《Journal of neurosurgery》1988,68(4):505-517
A multicenter, randomized placebo-controlled double-blind trial of nimodipine in poor-grade aneurysm patients was carried out in 17 Canadian hospitals. Of 188 patients enrolled in the trial, 32 were excluded for protocol violations and two were excluded due to statistical considerations, leaving 154 patients for valid outcome analysis. Nimodipine treatment was associated with a significantly better outcome (p less than 0.001): 21 (29.2%) of 72 nimodipine-treated patients had a good outcome at 3 months after subarachnoid hemorrhage (SAH) compared to eight (9.8%) of 82 placebo-treated patients. Delayed ischemic deficits from vasospasm alone were significantly less frequent in the nimodipine group (p less than 0.05) with permanent deficits occurring in five nimodipine-treated patients (6.9%) and in 22 placebo-treated patients (26.8%). Improvement in the good outcome rate and reduction in delayed ischemic deficits from vasospasm alone occurred in both Grade 3 and 4 patients, with no difference between nimodipine- and placebo-treated patients being found in Grade 5 patients. Repeat angiography after Day 4 was carried out in 124 patients. There was no significant difference in the incidence of moderate or severe diffuse spasm, which was seen in 64.3% of nimodipine-treated patients and 66.2% of placebo-treated patients. The authors conclude that nimodipine treatment in poor-grade patients with SAH results in an increase in the number of good outcomes and a reduction in the incidence of delayed neurological deterioration due to vasospasm. This effect occurs by a mechanism other than prevention of large-vessel spasm as visualized on angiography. 相似文献
16.
17.
WINOCOUR PH; KALUVYA S; BROWN L; FARRER M; MILLAR JP; NEIL HAW; ALBERTI KGMM 《QJM : monthly journal of the Association of Physicians》1991,79(3):539-560
Hyperinsulinaemia is said to be a risk factor for cardiovasculardisease, but the extent to which different insulinaemic measuresare associated with vascular risk factors in ostensibly healthyindividuals, and whether they operate independently in men andwomen, remains uncertain. The association between risk factors and various insulinaemicmeasures was examined in 148 men and 118 women who were normoglycaemic,normotensive, and non-obese (body mass index in men <27,in women <25). A 75 g glucose tolerance test was administeredafter blood sampling for fibrinogen, lipids, lipoproteins andinsulin. Insulin was also measured after 1 and 2 hours. Significantunivariate correlations (p<0.01) were most consistently recordedbetween insulinaemic measures and fasting serum triglyceridesin men and women, whilst systolic blood pressure only correlatedwith insulinaemia in women, and diastolic blood pressure correlatedwith fasting and 2 hour insulinaemic measures in men and women.Inconsistent associations were noted with total serum cholesterolin men and women, with high density lipoprotein cholesterol,body mass index, apoprotein B and A1 in men, and with fibrinogenin women. Age was not correlated with any insulinaemic measurein men or women. Differences in vascular risk factors between quintiles of theinsulinaemic measures were examined, after correction for bodymass index. The dominant association with fasting and post-glucoseload insulinaemic measures was with triglycerides, especiallyin women, with less frequent graded differences between quintilesobserved for total cholesterol, and diastolic and systolic bloodpressures in men and women. The incidence of other risk factors often only differed in thelowest or highest quintile in comparison to other quintiles,suggesting a threshold rather than a graded effect. Furthermore,differences in HDL cholesterol and apoprotein B were only recordedfor top quintiles of post-glucose challenge/integrated insulinaemicmeasures in men, whilst serum fibrinogen concentrations onlydiffered significantly in women in the top insulinaemic areaunder the curve quintile. In the absence of additional risk factors such as diabetes,hypertension and obesity, insulinaemic measures are not consistentlyrelated to blood pressure and measures of lipid metabolism andcoagulation, and are thus a weak predictor of other cardiovascularrisk factors. The vascular risk profile associated with insulinappears somewhat different in apparently healthy men and women. 相似文献
18.
19.
20.